Chromos and Xencor announce agreement for use of the ACE System to produce biologics. Read more about Chromos and Xencor announce agreement for use of the ACE System to produce biologics.
Xencor Granted Patent on Optimized Pharmaceutical Protein Read more about Xencor Granted Patent on Optimized Pharmaceutical Protein
Xencor Announces Harry Stylli As Its New Chief Executive Officer Read more about Xencor Announces Harry Stylli As Its New Chief Executive Officer
Xencor Announces Bassil Dahiyat As Its New Chief Scientific Officer Read more about Xencor Announces Bassil Dahiyat As Its New Chief Scientific Officer
Xencor and Protein Design Labs Initiate Partnership for Optimized Antibodies Read more about Xencor and Protein Design Labs Initiate Partnership for Optimized Antibodies
Xencor Determines Structure Of Baff, A Key Autoimmune Disease Target Read more about Xencor Determines Structure Of Baff, A Key Autoimmune Disease Target
Xencor and Roche Extend XmAb™ Antibody Therapeutics Collaboration Read more about Xencor and Roche Extend XmAb™ Antibody Therapeutics Collaboration
Xencor Presents Findings on New Aspect of its Fc Technology Targeting Autoimmune Disease Read more about Xencor Presents Findings on New Aspect of its Fc Technology Targeting Autoimmune Disease
Xencor Gives Panel Presentation and Company Update at BIO InvestorForum; Announces Recent Close of $20 Million in Financing Read more about Xencor Gives Panel Presentation and Company Update at BIO InvestorForum; Announces Recent Close of $20 Million in Financing
Xencor Announces Protein Optimization Collaboration with Lilly Read more about Xencor Announces Protein Optimization Collaboration with Lilly
